Ablative Prostate Boost + Androgen Deprivation Therapy (ADT) + Androgen Receptor Pathway Inhibitors (ARPIs) + Higher Nodal Dose Escalation + Ultrahypofractionated Whole-Pelvis Radiotherapy for neoplasm metastasis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 23 Feb 2026: Trial registered, NCT07426094
  2. 19 Mar 2026: Trial started, NCT07426094

The trials

NCT07426094: PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer

State
Under way
Phase
Phase 2 and Phase 3
People
600 planned
Started
19 Mar 2026
Primary completion
1 Dec 2033
Arms
Arm 4: A1B2 - Prostate Boost + Higher Nodal Dose
Results
None posted
  1. 23 Feb 2026: Trial registered
  2. 19 Mar 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.